Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma:Final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group

MLA

Andreas Engert, et al. Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma:Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. Jan. 2019. EBSCOhost, https://doi.org/10.1200/JCO.19.00964.

APA

Andreas Engert, Carsten Kobe, Bernd Hertenstein, Bastian von Tresckow, Max S. Topp, Michael Fuchs, Markus Dietlein, Helen Goergen, Andreas Lohri, Volker Diehl, Josee M. Zijlstra, Julia Meissner, Andreas Rosenwald, Julia Thiemer, Georg Kuhnert, Stephanie Sasse, Peter Borchmann, Georg Maschmeyer, Martin Vogelhuber, … Ulrich Keller. (2019). Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma:Final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group. https://doi.org/10.1200/JCO.19.00964

Chicago

Andreas Engert, Carsten Kobe, Bernd Hertenstein, Bastian von Tresckow, Max S. Topp, Michael Fuchs, Markus Dietlein, et al. 2019. “Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma:Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group,” January. doi:10.1200/JCO.19.00964.